Results 91 to 100 of about 16,205 (225)

Analysis of Bordetella pertussis pertactin and pertussis toxin types from Queensland, Australia, 1999–2003

BMC Infectious Diseases, 2006
Background In Australia two acellular Bordetella pertussis vaccines have replaced the use of a whole cell vaccine. Both of the licensed acellular vaccines contain the following three components; pertussis toxoid, pertussis filamentous haemagglutinin and ...
Slack Andrew T, Byrne Shane
doaj   +1 more source

Immunogenicity and protective efficacy of a newly developed tri-component diphtheria, tetanus, and acellular pertussis vaccine in a murine model

Journal of Microbiology, Immunology and Infection, 2018
Background/Purpose: Although assessing the immunogenicity and protective efficacy of acellular pertussis (aP) vaccines via murine model studies faces limitations, preliminary assessments have been achieved by evaluating respiratory challenge and humoral ...
Dong Ho Huh, Seung Beom Han, Hye Jo Shin, Dong Ho Ahn, Gi Sub Choi, Kyu Ri Kang, Bo Ram Kim, Jin Han Kang   +7 more
doaj   +1 more source

Validation of the Vaccination Confidence Scale: A Brief Measure to Identify Parents at Risk for Refusing Adolescent Vaccines [PDF]

, 2016
Objective To validate a brief measure of vaccination confidence using a large, nationally representative sample of parents. Methods We analyzed weighted data from 9018 parents who completed the 2010 National Immunization Survey–Teen, an annual ...
Brewer, Joseph M., Dempsey, Amanda F., Gilkey, Melissa, Magnus, Brooke E., McRee, Annie-Laurie, Reiter, Paul   +5 more
core   +3 more sources

Bordetella pertussis Strain Lacking Pertactin and Pertussis Toxin

Emerging Infectious Diseases, 2016
A Bordetella pertussis strain lacking 2 acellular vaccine immunogens, pertussis toxin and pertactin, was isolated from an unvaccinated infant in New York State in 2013.
Margaret M. Williams, Kathryn Sen, Michael R. Weigand, Tami H. Skoff, Victoria A. Cunningham, Tanya A. Halse, M. Lucia Tondella   +6 more
doaj   +1 more source

Evolution of Bordetella pertussis in the acellular vaccine era in Norway, 1996 to 2019. [PDF]

Eur J Clin Microbiol Infect Dis, 2022
Brandal LT, Vestrheim DF, Bruvik T, Roness RB, Bjørnstad ML, Greve-Isdahl M, Steens A, Brynildsrud OB.   +7 more
europepmc   +1 more source

A system-view of Bordetella pertussis booster vaccine responses in adults primed with whole-cell versus acellular vaccine in infancy. [PDF]

JCI Insight, 2021
da Silva Antunes R, Soldevila F, Pomaznoy M, Babor M, Bennett J, Tian Y, Khalil N, Qian Y, Mandava A, Scheuermann RH, Cortese M, Pulendran B, Petro CD, Gilkes AP, Purcell LA, Sette A, Peters B.   +16 more
europepmc   +1 more source

Determination of Serum Antibody to Bordetella pertussis Adenylate Cyclase Toxin in Vaccinated and Unvaccinated Children and in Children and Adults with Pertussis [PDF]

, 2017
Presence of antibody to adenylate cyclase toxin (ACT) has been noted following Bordetella pertussis infection. Because ACT is not presently in any acellular pertussis vaccines, it has been considered as a possible antigen to use in B.
Cherry, James D., Corbel, Michael J., Heininger, Ulrich, Newland, Penny, Patel, Kashmira, Xing, Dorothy X. L.   +5 more
core  

Low tetanus-diphtheria-acellular pertussis (Tdap) vaccine coverage among healthcare workers in a quaternary university hospital in São Paulo, Brazil: need for continuous surveillance and implementation of active strategies

Brazilian Journal of Infectious Diseases, 2019
Introduction: Vaccination with tetanus-diphtheria-acellular pertussis (Tdap) has been recommended for healthcare workers (HCWs) by Brazilian Ministry of Health since November 2014. Objective: To describe the strategies implemented to improve Tdap uptake,
Bruno Azevedo Randi, Karina Takesaki Miyaji, Amanda Nazareth Lara, Karim Yaqub Ibrahim, Vanessa Infante, Camila Cristina Martines Rodrigues, Marta Heloísa Lopes, Ana Marli Christovam Sartori   +7 more
doaj   +1 more source

Avidity of pertussis toxin antibodies following vaccination with genetically versus chemically detoxified pertussis toxin-containing vaccines during pregnancy

Frontiers in Immunology
BackgroundBoth the quantity and quality of circulating anti-pertussis toxin antibodies are important for protection against severe pertussis. We compared the avidity of PT-IgG antibodies in pregnant women and their infants following vaccination during ...
Bahaa Abu-Raya, Bahaa Abu-Raya, Bahaa Abu-Raya, Giuseppe Del Giudice, Anita H. J. van den Biggelaar, Yuxiao Tang, Niranjan Bhat, Hong Thai Pham, Wassana Wijagkanalan   +8 more
doaj   +1 more source

PERTUSSIS IS COMING BACK? IMPROVEMENT OF FORGOTTEN CHILDHOOD INFECTION CONTROL

Педиатрическая фармакология, 2012
Infection that more than 60 years ago was recognized one of the leading childhood diseases that caused infant mortality, is returning. Of course, with the introduction of vaccination against pertussis in the national programs, we rarely meet severe ...
M. V. Fedoseenko, M. G. Galitskaya, M. I. Ivardava, A. G. Gaivoronskaya, N. A. Mayansky, V. V. Botvinieva, T. V. Rodionova   +6 more
doaj   +1 more source